日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapy

HIV-1 Gag保守元件DNA疫苗在接受抗逆转录病毒治疗的HIV感染者中的免疫原性

Jacobson, Jeffrey M; Felber, Barbara K; Chen, Huichao; Pavlakis, George N; Mullins, James I; De Rosa, Stephen C; Kuritzkes, Daniel R; Tomaras, Georgia D; Kinslow, Jennifer; Bao, Yajing; Olefsky, Maxine; Rosati, Margherita; Bear, Jenifer; Heptinstall, Jack R; Zhang, Lu; Sawant, Sheetal; Hannaman, Drew; Laird, Gregory M; Cyktor, Joshua C; Heath, Sonya L; Collier, Ann C; Koletar, Susan L; Taiwo, Babafemi O; Tebas, Pablo; Wohl, David A; Belaunzaran-Zamudio, Pablo F; McElrath, M Juliana; Landay, Alan L

Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial

抗逆转录病毒疗法在急性或早期 HIV 感染期间对病毒学和免疫学结果的影响:一项多国临床试验的结果

Crowell, Trevor A; Ritz, Justin; Zheng, Lu; Naqvi, Asma; Cyktor, Joshua C; Puleo, Joseph; Clagett, Brian; Lama, Javier R; Kanyama, Cecilia; Little, Susan J; Cohn, Susan E; Riddler, Sharon A; Collier, Ann C; Heath, Sonya L; Tantivitayakul, Pornphen; Grinsztejn, Beatriz; Arduino, Roberto C; Rooney, James F; van Zyl, Gert U; Coombs, Robert W; Fox, Lawrence; Ananworanich, Jintanat; Eron, Joseph J; Sieg, Scott F; Mellors, John W; Daar, Eric S

U.S. patient preferences for long-acting HIV treatment: a discrete choice experiment

美国患者对长效HIV治疗药物的偏好:一项离散选择实验

Graham, Susan M; Barthold, Douglas; Hauber, Brett; Brah, Aaron T; Saldarriaga, Enrique; Collier, Ann C; Ho, Rodney J Y; Marconi, Vincent C; Simoni, Jane M

Varied Patterns of Decay of Intact Human Immunodeficiency Virus Type 1 Proviruses Over 2 Decades of Antiretroviral Therapy

抗逆转录病毒疗法二十余年间,完整人类免疫缺陷病毒1型前病毒衰减模式的多样性

Gandhi, Rajesh T; Bosch, Ronald J; Mar, Hanna; Laird, Gregory M; Halvas, Elias K; Hovind, Laura; Collier, Ann C; Riddler, Sharon A; Martin, Albine; Ritter, Kristen; McMahon, Deborah K; Eron, Joseph J; Cyktor, Joshua C; Mellors, John W

A novel formulation enabled transformation of 3-HIV drugs tenofovir-lamivudine-dolutegravir from short-acting to long-acting all-in-one injectable

一种新型制剂使得三种抗HIV药物替诺福韦-拉米夫定-多替拉韦从短效制剂转变为长效一体化注射剂。

Perazzolo, Simone; Stephen, Zachary R; Eguchi, Masa; Xu, Xiaolin; Delle Fratte, Rachele; Collier, Ann C; Melvin, Ann J; Ho, Rodney J Y

Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance

对于病毒学治疗失败后继续接受基于蛋白酶抑制剂的抗逆转录病毒方案治疗且无或仅有轻微耐药性的HIV感染者,预测其病毒学疗效的因素是什么?

Salata, Robert A; Grinsztejn, Beatriz; Ritz, Justin; Collier, Ann C; Hogg, Evelyn; Gross, Robert; Godfrey, Catherine; Kumarasamy, Nagalingeswaran; Kanyama, Cecilia; Mellors, John W; Wallis, Carole L; Hughes, Michael D

Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial

在资源匮乏地区,包括拉替拉韦 (RAL)、达芦那韦 (DRV/r) 和/或依曲韦林 (ETR) 在内的三线抗逆转录病毒疗法耐受性良好,并可在 144 周内实现持久的病毒学抑制:ACTG A5288 策略试验

Avihingsanon, Anchalee; Hughes, Michael D; Salata, Robert; Godfrey, Catherine; McCarthy, Caitlyn; Mugyenyi, Peter; Hogg, Evelyn; Gross, Robert; Cardoso, Sandra W; Bukuru, Aggrey; Makanga, Mumbi; Badal-Aesen, Sharlaa; Mave, Vidya; Ndege, Beatrice Wangari; Fontain, Sandy Nerette; Samaneka, Wadzanai; Secours, Rode; Van Schalkwyk, Marije; Mngqibisa, Rosie; Mohapi, Lerato; Valencia, Javier; Sugandhavesa, Patcharaphan; Montalban, Esmelda; Munyanga, Cornelius; Chagomerana, Maganizo; Santos, Breno R; Kumarasamy, Nagalingeswaran; Kanyama, Cecilia; Schooley, Robert T; Mellors, John W; Wallis, Carole L; Collier, Ann C; Grinsztejn, Beatriz

Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy

HIV感染者亚临床冠状动脉疾病的蛋白质组学特征:REPRIEVE机制子研究分析

Kolossváry, Márton; deFilippi, Chris; Lu, Michael T; Zanni, Markella V; Fulda, Evelynne S; Foldyna, Borek; Ribaudo, Heather; Mayrhofer, Thomas; Collier, Ann C; Bloomfield, Gerald S; Fichtenbaum, Carl; Overton, Edgar T; Aberg, Judith A; Currier, Judith; Fitch, Kathleen V; Douglas, Pamela S; Grinspoon, Steven K

The systematic development of attributes and levels for a discrete choice experiment of HIV patient preferences for long-acting antiretroviral therapies in the United States

美国艾滋病患者对长效抗逆转录病毒疗法的偏好离散选择实验中属性和水平的系统性开发

Brah, Aaron T; Barthold, Douglas; Hauber, Brett; Collier, Ann C; Ho, Rodney J Y; Marconi, Vincent C; Simoni, Jane M; Graham, Susan M

Transportability From Randomized Trials to Clinical Care: On Initial HIV Treatment With Efavirenz and Suicidal Thoughts or Behaviors

从随机试验到临床护理的可转化性:依非韦伦初始HIV治疗与自杀念头或行为的关系

Mollan, Katie R; Pence, Brian W; Xu, Steven; Edwards, Jessie K; Mathews, W Christopher; O'Cleirigh, Conall; Crane, Heidi M; Eaton, Ellen F; Collier, Ann C; Weideman, Ann Marie K; Westreich, Daniel; Cole, Stephen R; Tierney, Camlin; Bengtson, Angela M